Potential acute lowering of glucose does not fully mitigate downstream effects already initiated by hyperglycemia such as enhanced inflammation, endothelial cell dysfunction, neutrophil adhesion, MMP-9 activity, and ROS production. The gene discussed is MMP9; the disease is Hyperglycemia.